Case Report
Year: 2022 | Month: April | Volume: 12 | Issue: 4 | Pages: 316-320
DOI: https://doi.org/10.52403/ijhsr.20220437
Hypertriglyceridemia in a COVID-19 Patient: A Case Report
Alfateh M. Noor2, Zohdi Farea1, Shakya Majumder2, Raja Bilal Zafar2, Abdallah Balhamar1, Ahmed F. Mady1
1Critical Care Department, King Saud University Medical City, Riyadh, KSA
2Charing Cross Hospital, Imperial College Trust, London, UK
Corresponding Author: Alfateh M. Noor
ABSTRACT
Most laboratory findings of coronavirus disease (COVID-19) are not specific nor are they reliable in assessing response to treatments. This case report outlines a rare finding of severe hypertriglyceridemia in a COVID-19 patient and, more interestingly, it sheds light on a correlation between clinical improvement and a decrease in hypertriglyceridemia after plasmapheresis treatment. Using a normal triglyceride level as a target for our plasmapheresis treatment resulted in dramatic improvement in our patient’s condition. The patient was treated successfully and discharged from the hospital after nine days.
Key words: SARS-CoV-2, COVID-19, Hypertriglyceremia.